Bavarian Nordic – Presentation of 2022 Annual Report

Bavarian Nordic is expected to announce its annual report for 2022 on 2 March 2023. The next day on 3 March at 14:30, you can meet and ask questions to Bavarian Nordic's VP of Investor Relations & Communications, Rolf Sass Sørensen, in a virtual live event.

The vaccine company has already announced its preliminary results for 2022. In 2022, revenue was DKK 3,151 million, thus exceeding the company's latest guidance range of DKK 2,800-3,000 million. The operating profit (EBITDA) ended at DKK 329 million, which also was above the latest guidance range of DKK -200 million and DKK 0 million. Moreover, Bavarian Nordic's cash and cash equivalents amounted to DKK 1,742 million by the end of 2022, also above expectations of more than DKK 1,700 million. In addition to that, the company has also repaid bank debt of DKK 600 million.

As the preliminary results for 2022 are published, the focus of the event is expected to be on Bavarian Nordic's financial expectations for 2023 as well as updates on the company's pipeline.

Disclaimer: HC Andersen Capital receives payment from Bavarian Nordic for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup 10:14, 14 February 2023.